Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study.
Unilateral subthalamotomy in the treatment of Parkinson's disease.
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
Bilateral subthalamotomy for advanced Parkinson disease.
Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months.
Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease.
Metabolic changes following subthalamotomy for advanced Parkinson's disease.
This minimizes medication-induced dyskinesia, which may interfere with intraoperative microelectrode recordings and with the assessment of clinical improvement during intraoperative stimulation including the subthalamotomy effect.
As the subthalamotomy effect wanes, which may take between I and 14 days, the patient's medication may require adjustment but care must be taken to neither under nor over medicate.